Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 31.22
-0.94 (-2.92%)
Jan 21, 2026, 2:14 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 135 employees as of December 31, 2024. The number of employees decreased by 33 or -19.64% compared to the previous year.
Employees
135
Change (1Y)
-33
Growth (1Y)
-19.64%
Revenue / Employee
1.34M SEK
Profits / Employee
-4.82M SEK
Market Cap
3.27B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 135 | -33 | -19.64% |
| Dec 31, 2023 | 168 | 18 | 12.00% |
| Dec 31, 2022 | 150 | 19 | 14.50% |
| Dec 31, 2021 | 131 | 44 | 50.57% |
| Dec 31, 2020 | 87 | 13 | 17.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 114 |
| Oncopeptides AB | 80 |
| Egetis Therapeutics AB | 40 |
| Diamyd Medical AB | 39 |
| Genovis AB (publ.) | 32 |
| Vicore Pharma Holding AB | 29 |
| Xspray Pharma AB | 27 |
| Saniona AB | 22 |
Hansa Biopharma AB News
- 6 days ago - Hansa Biopharma AB at JPMorgan Healthcare Conference Transcript - GuruFocus
- 6 days ago - Hansa Biopharma AB (publ) (HNSBF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation - PRNewsWire
- 2 months ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases Transcript - Seeking Alpha
- 2 months ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases - Slideshow - Seeking Alpha
- 2 months ago - Hansa Biopharma AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Hansa Biopharma AB (publ) (HNSBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Hansa Biopharma AB (HNSBF) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue ... - GuruFocus